Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumors.
The authors have developed a hand-held gamma-detecting probe (GDP) for intraoperative use that improves the sensitivity of external radioimmunodetection. Radiolabeled monoclonal antibody (MAb) B72.3 was injected in six patients with primary colorectal cancer and 31 patients with recurrent colorectal cancer an average of 16 days preoperatively. The GDP localized the MAb B72.3 in 83 percent of sites. The technique, known as a radioimmunoguided surgery (RIGS) system did not alter the surgical procedure in patients with primary colorectal cancer but did alter the approach in 26 percent (8/31) of patients with recurrent colorectal cancer. Two patients avoided unnecessary liver resections and two underwent extraabdominal approaches to document their disease. The RIGS system may influence the short-term morbidity and mortality of surgery for colorectal cancer. Larger series and longer follow-up are needed to determine whether the RIGS system confers a survival advantage to the patient with colorectal cancer.
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm / Q000276:immunology; D003110:Colonic Neoplasms / Q000000981:diagnostic imaging / Q000601:surgery*; D003107:Colorectal Surgery / Q000295:instrumentation* / Q000379:methods; D005069:Evaluation Studies as Topic; D005189:False Positive Reactions; D006023:Glycoproteins / Q000276:immunology; D006801:Humans; D007432:Intraoperative Period; D007457:Iodine Radioisotopes; D007553:Isotope Labeling; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging / Q000601:surgery; D011877:Radionuclide Imaging; D012004:Rectal Neoplasms / Q000000981:diagnostic imaging / Q000601:surgery*; D012811:Sigmoid Neoplasms / Q000000981:diagnostic imaging / Q000601:surgery
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D006023:Glycoproteins; D007457:Iodine Radioisotopes; C047052:tumor-associated antigen 72